T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common nutrient shield young cancer patients from Chemo's toxic side effects?
Disease control Recruiting nowThis study aims to see if adding a nutrient supplement called levocarnitine to standard chemotherapy can protect the liver in adolescents and young adults (ages 15-39) being treated for leukemia or lymphoma. A key chemotherapy drug, asparaginase, often causes severe liver damage …
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo aims to wipe out leukemia in adults
Disease control Recruiting nowThis study is testing a combination of chemotherapy drugs and a newer enzyme-blocking drug (JZP458) to treat adults newly diagnosed with a fast-growing blood cancer called acute lymphoblastic leukemia (ALL). The goal is to see if this combination can eliminate cancer cells more e…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug cocktail tested in battle against aggressive blood cancers
Disease control Recruiting nowThis study is testing a combination of several chemotherapy drugs to treat adults with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma. The goal is to see if adding the drugs nelarabine, pegaspargase, and venetoclax to a standard inten…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC